Recent progress in growth factor research has revealed that cancer cells produce epidermal growth factor (EGF)/ transforming growth factor (TGF)-a-like biological activity. The activity produced by several tumour cell lines has been characterised and is considered to be TGF-oa (Marquardt et al., 1983; Perroteau et al., 1986; Derynck et al., 1987; Smith et al., 1987) . Also, the expression of TGF-oa mRNA in several tumour cell lines has been revealed . However, it has been reported that some gastric cancer cell lines produce EGF (Mori et al., 1987) and some breast cancer cell lines express EGF mRNA (Murphy et al., 1988) . With the aim of clarifying whether the major factor with EGF/TGF-oc-like biological activity produced by human tumour cells is TGF-a or EGF, we have examined tumour cell lines for production of TGF-a and EGF by using the respective radioimmunoassay (RIA) as well as the radioreceptor assay (RRA). In the RRA, EGF/TGF-a-like activity (EGF/TGF-a-LA), representing factors with capacity to bind to EGF receptor, could be detected. Since the present study demonstrated that melanoma cell lines produce a large amount of TGF-a with high frequency, TGF-a production by the melanoma cell lines was further analysed by Northern blot hybridisation and gel filtration techniques.
Materials and methods

Human tumour cell lines
The 41 human tumour cell lines examined in this study were from seven melanomas (SEKI, A-375, VMRC-MELG, G-361, WM-115, WM-226-4 and Mewo), four lung adenocarcinomas , two lung squamous cell carcinomas (VMRC-LCP and EBC-1), three lung small cell carcinomas , seven gastric carcinomas (KATO-III, MKN-7, MKN-28, , three hepatocellular carcinomas (Li-7, PLC/PRF/5 and HuH-7), three mammary carcinomas (MCF-7, and ZR-75-1), two colonic carcinomas , four pancreatic carcinomas (MIAPaCa-2, ASPC-1, PANC-1 and BxPC-3), three urinary bladder carcinomas (T-24, HT-1197 and HT-1376), an acute promyelocytic leukaemia (HL-60), an acute lymphoblastic leukaemia (Molt-4) and an epitheloid Correspondence: K. Imanishi. Received 2 November 1988, and in revised form, 16 January 1989. carcinoma (Hela). SEKI (Fujita et al., 1980) , Lu-130, Lu-134-A, Lu-135 (Terasaki et al., 1986) and Li-7 (Beattie et al., 1982) were established at the National Cancer Center Research Institute (Tokyo, Japan). (Motoyama et al., 1986) and KITAJIMA (Hitomi et al., 1986) were kindly provided by Dr Hidenobu Watanabe (Niigata University, Niigata, Japan). PC-7, PC-9 and PC-14 (Lee et al., 1985b) were kindly provided by Dr Yoshihiro Hayata (Tokyo Medical College, Tokyo, Japan). A-375, G-361, WM-115, WM-266-4, A-549, KATO-I1I, MCF-7, BT-20, ZR-75-1, HT-29, MIAPaCa-2, ASPC-1, PANC-1, BxPC-3, T-24, HT-1197, HT-1376, HL-60, Molt-4 and Hela (American Type Culture Collection, 1985) (Tokyo, Japan) . All of these cell lines were maintained at 37°C under 5% CO2 95% air in 75cm2 plastic tissue culture flasks by using the original medium described in the references and the catalogues. The culture media for all these cell lines were supplemented with 10% fetal calf serum (FCS) . When the cells had grown to 90% confluence, the spent media of these cell lines were collected and analysed.
Extraction method The spent medium (10 ml) was applied to an activated octadecylsilylsilica (ODS) cartridge (Sep-pak C 18, Waters, Milford, MA, USA). The material retained on the ODS cartridge was eluted with 3ml of 80% acetonitrile in 0.1% trifluoroacetic acid. The eluates were lyophilised and reconstituted to 1.0 ml with assay buffer (Imanishi et al., 1988) . As control, the same volume of fresh medium (newly prepared culture medium supplemented with 10% FCS) for each human tumour cell line was extracted in the same manner. Furthermore, to determine the recovery rate of the extraction method, recombinant human (h) TGF-ax(1-50) and hEGF(1-53) purchased from Earth Chemical (Akoh, Japan) were added to fresh medium and extracted.
RRA and RIAs
The levels of factors with capacity to bind to EGF receptor, EGF/TGF-a-LA, were determined by RRA, which was carried out by using the membrane fraction prepared from a C) The Macmillan Press Ltd., 1989 Br. J. Cancer (1989 human epidermoid carcinoma cell line, A43 1, by the method reported previously (Imanishi et al., 1988) . Recombinant hTGF-ac(I-50) was used as the assay standard and recombinant hEGF radioiodinated by the chloramine-T method (Hunter & Greenwood, 1962) was used as the labelled antigen.
Human TGF-a RIA was performed by using an antiserum against hTGF-a(1-7) as described previously (Imanishi et al., 1988) . Recombinant hTGF-cx(I-50) was used as the assay standard and the labelled antigen.
Human EGF RIA was performed with a rabbit antiserum (TRK-102) raised against highly purified hEGF from human urine, which was provided by Earth Chemical. Recombinant hEGF was used as the assay standard and labelled antigen. To test whether this assay system could recognise authentic hEGF, 10 urine specimens prepared from healthy volunteers were assayed by the hEGF RIA.
The specificity of these assay systems was determined by using recombinant hTGF-a(I-50), hTGF-a(1-7), hTGF-oc(33-50) and recombinant hEGF. The results were expressed as equivalents to nmol of the respective growth factors per litre of spent media (nmol 1 -1).
Gel filtration studies of TGF-a in melanoma cell lines Extracts prepared from the spent media of four melanoma cell lines were chromatographed on a Sephadex G-50 superfine column (1.0 x 45 cm) which was equilibrated and eluted with I mol I1-acetic acid. The column was calibrated with hTGF-ax(I-50) and the samples were always supplemented with 1251-human albumin and Na125I as internal markers.
Northern blot analysis in melanoma cell lines Northern blot hybridisation for hTGF-ac mRNA was also performed with the seven melanoma cell lines by the method described previously . For detecting hTGF-a mRNA, a 60-base probe complementary to hTGFat(1-20) was used ( Figure 1 ). Furthermore, in order to compare the amount of poly(A)+ RNA prepared from each cell line, the levels of human P-actin mRNA were determined by the method described previously (Suzuki et al., 1987) . Densitometric analysis was performed with a computing densitometer (Suzuki et al., 1987) , and the amounts of hTGF-a mRNA in the respective cells were estimated as the ratio of hTGF-a mRNA to /3-actin mRNA.
Results
RRA and RIAs
The amounts of hTGF-a which inhibited the labelled antigen binding by 10% and 50% were 30 and 900 fmol per tube, respectively, when determined by RRA, and hTGF-a RIA, gave figures of 26 and 150 fmol per tube, respectively. In the case of hEGF RIA, the amounts of hEGF were 2.1 and 9.2fmol per tube, respectively. Cross-reactivities of hTGF-ax, fragments and hEGF in these assay systems are summarised in Table I The levels of EGF/TGF-a-LA, IR-TGF-cx and IR-EGF in the 41 spent media prepared from human tumour cell lines were determined by the three assay systems and the results were expressed as the concentrations (nmoll-1) equivalent to the respective growth factors. As shown in Figure 2a , EGF/ TGF-a-LA was detected in 11 spent media. The doseresponse curves were parallel to that of hTGF-a(1-50). It is worth noting that the frequency of TGF-a production and its quantity in melanoma cell lines are high. As shown in Figure 2b , the levels of IR-TGF-a were approximately equal to those determined by RRA. In all of the 11 lines in which EGF/TGF-a-LA was detected, IR-TGF-a was also detected. Furthermore, a small amount of IR-TGF-a was detected in an additional five lines. In the 11 cell lines producing both EGF/TGF-cl-LA and IR-TGF-ax, the levels of EGF/TGF-a-LA correlated well with those of IR-TGF-a (r = 0.994, P <0.005) (Figure 3 ). In contrast, no IR-EGF was detected in the spent media.
Gel filtration studies of TGF-a in melanoma cell lines The gel filtration patterns of the extracts prepared from the spent media of four melanoma cell lines are shown in Figure  4 . Both hTGF-a RIA and RRA revealed a single peak at the position corresponding to hTGF-a(1-50) in the three cell lines. In the case of G-361, however, the major peak with IR-TGF-oa was eluted at a position between hTGF-a(l-50) and 125I-Na. RRA revealed that the major peak had the ability to bind to the EGF receptor. When the extract prepared from fresh medium was examined, no detectable peak was observed.
Northern blot analysis in melanoma cell lines Autoradiographs of Northern blot analysis using the probes for hTGF-cc mRNA and P-actin mRNA are shown in Figure   5 . Two bands were detected by the probe for hTGF-a mRNA in the four melanoma cell lines which produced a large amount of IR-TGF-ax. The molecular sizes of these bands were 4.8 and 1.8kb, respectively. When the probe for ,B-actin mRNA was used, a 2.0 kb band was detected in each cell line. The ratios of hTGF-a mRNA to ,B-actin mRNA were calculated and are shown in Table II 
Discussion
In the present study, 11 out of 41 human tumour cell lines (27%) were found to produce EGF/TGF-oa-LA when they were examined by RRA using the membrane fraction of A-431 cells. Simultaneous analysis of these 41 cell lines by hTGF-ax RIA revealed that 16 (39%) of them secreted IR- HA, 125I-human albumin; TGF-a, hTGF-c(I-50); 1251, 125I-Na.
TGF-ac. It is worth noting that all of the 11 lines producing EGF/TGF-a-LA produced IR-TGF-a. In contrast, IR-EGF was not detectable in any of these 41 cell lines. The facts that the levels of EGF/TGF-a-LA correlated well with those of IR-TGF-a and that the detection ability of hEGF RIA is 10 times better than that of hTGF-a RIA or RRA indicate that EGF/TGF-a-LA detected in the spent media of these human tumour cell lines is TGF-a rather than EGF. TGF-a with a molecular size of 6kDa has been purified from transformed rodent and human cells, sequenced and cloned (Derynck et al., 1984; Lee et al., 1985a) . On the other hand, TGF-a-like activity of substances with different molecular sizes has been detected in the spent media and tumour cell extracts in several tumour cells (Bringman et al., 1987; Teixido et al., 1987) . We also have demonstrated that TGF-a produced by human lung adenocarcinoma cell lines has multiple molecular sizes; these were considered to be macromolecular TGF-a, TGF-a(I-50) and molecules with lower molecular sizes (Imanishi et al., 1988) . In the present study, we determined the molecular sizes of TGF-x produced by melanoma cell lines, in which the frequency of TGF-cx production and its quantity were high. Gel filtration studies revealed that the molecular size of EGF/TGF-a-LA and IR-TGF-a was identical to that of hTGF-at(l-50) in three of the four melanoma cell lines examined. In the case of G-361, however, the majir peak was eluted at a position behind that of hTGF-a(I-50). The position of this peak eluted in the present gel filtration suggests that this molecule is different from those observed in the extracts prepared from the spent media of human lung adenocarcinoma cell Table   *. lines (Imanishi et al., 1988) . Since both EGF/TGF' LA and IR-TGF-a were detected in this peak, further characterisation of this molecule may add information on the structure biological activity relationship of the TGF-!.
molecule.
Northern blot analysis revealed that TGF-a produced by the melanoma cell lines was actually the product of hTGF-cx gene, according to the findings described below. Bands corresponding to hTGF-a mRNA were detected in the four melanoma cell lines producing a large amount of IR-TGF-oc. The molecular sizes of these bands were almost the same as those of hTGF-a mRNA reported by Derynck et al. (1987) and Coffey et al. (1987) . Furthermore, the amount of hTGF-oa mRNA correlated well with the concentration of IR-TGF-a in each cell line. It is worth noting that the pattern of hTGF-cx mRNA of G-361, in which TGF-a with different molecular size was detected, was the same as that of the other melanoma cell lines expressing hTGF-a mRNA.
The finding that the frequency of TGF-a production and its quantity in melanoma cell lines are high suggests that TGF-a plays an important role in these cells. There are several reports of the production of TGF-oa by melanoma cell lines (Marquardt et al., 1983; Derynck et al., 1987; Ellem et al., 1988) . Since TGF-a has been considered to be one of the possible autocrine growth factors in cancer cells, several studies were performed previously to clarify the role of TGF-a as the autocrine growth factor for melanoma cells. Singletary et al. (1987) reported that EGF enhanced the growth of almost all melanoma cells prepared from surgical specimens. Ellem et al. (1988) reported that in melanoma cells and melanocytes the secretion of TGF-a was stimulated by ultraviolet radiation and that TGF-a promoted their own growth. In contrast, Kudlow et al. (1984) reported that a monoclonal antibody against EGF receptor did not inhibit the cellular growth of a melanoma cell line, suggesting that TGF-oc could not function as an autocrine growth factor for melanoma cells. As stated above, it is controversial at present whether or not TGF-a is an autocrine growth factor for melanoma cells. Further studies on this point should clarify the actual roles of TGF-a in melanoma cells.
